Skip to main content
. 2019 Oct 1;67(8):1103–1109. doi: 10.1136/jim-2019-001003

Table 1.

Clinical features and laboratory test results of 189 consecutive critically ill patients with acute kidney injury (AKI)

Characteristics All patients with AKI (n=189) Survived group (n=119) Non-survived group (n=70) P value
Mean ages (year)
(means±SD)
63.33±18.294 61.73±18.997 66.06±16.813 <0.001
Gender (male), n (%) 139 (73.5) 88 (73.9) 51 (72.9) 0.937
Gender (female), n (%) 50 (26.5) 31 (26.1) 19 (27.1)
SCr (μmol/L) (medians) 165.0 (133.0, 238.0) 166.0 (122.2, 359.2) 165.0 (138.0, 215.5) 0.716
BUN (mmol/L) (medians) 15.3 (9.8, 22.3) 13.9 (9.2, 21.5) 15.9 (10.8, 23.1) 0.307
Ua (medians) 0.4 (0.3, 0.6) 0.4 (0.3, 0.6) 0.4 (0.3, 0.5) 0.680
ALT (IU/L) (medians) 33.0 (20.0, 65.5) 41.0 (25.0, 85.0) 26.5 (17.0, 52.8) 0.004
TB (medians) 12.1 (8.3, 20.9) 12.3 (8.2, 18.7) 12.0 (9.2, 20.9) 0.870
Prealbumin (mg/L) (medians) 135.0 (95.0, 196.0) 134.5 (98.5, 176.2) 135.0 (94.0, 206.0) 0.699
Blood glucose (mmol/L) (medians) 6.9 (5.4, 9.5) 7.3 (5.5, 10.1) 6.5 (5.4, 8.5) 0.283
C reactive protein (μg/L) (medians) 69.1 (18.6, 122.0) 69.1 (20.0, 132.5) 69.7 (15.7, 119.0) 0.363
TG (medians) 1.6 (1.0, 2.8) 1.9 (1.2, 3.2) 1.4 (0.9, 1.9) 0.072
CHO (medians) 3.5 (2.7, 4.4) 3.6 (2.8, 4.3) 3.4 (2.6, 4.4) 0.512
LDL (medians) 2.4 (1.7, 3.0) 2.4 (1.8, 2.9) 2.4 (1.6, 3.0) 0.802
Albumin (g/L)
(means±SD)
32.3±6.9 31.6±7.2 32.9±6.6 0.215
HDL (means±SD) 0.8±0.4 0.7±0.4 0.9±0.4 0.091
Na (mmol/L) (medians) 140.0 (136.0, 148.8) 140.0 (135.0, 149.0) 140.0 (137.0, 147.0) 0.791
Cl (mmol/L) (medians) 103.0 (98.0, 111.0) 103.0 (98.0, 113.0) 102.0 (97.0, 111.0) 0.582
K (mmol/L) (means±SD) 4.2±0.9 4.2±0.9 4.2±0.9 0.555
Ca (mmol/L) (means±SD) 2.1±0.3 2.0±0.3 2.1±0.2 0.505
P (mmol/L) (medians) 1.2 (0.9, 1.6) 1.4 (1.0, 1.7) 1.2 (0.8, 1.4) 0.042
WCC (×103/μL) (medians) 11.5 (7.7, 16.7) 11.7 (9.1, 16.4) 11.0 (7.0, 16.9) 0.490
RBC (×1012/L) (means±SD) 3.7±0.9 3.8±0.9 3.7±0.8 0.227
HCT (means±SD) 33.6±7.2 34.0±8.3 33.2±6.1 0.495
Platelets(×109/L) (means±SD) 155.5±95.0 167.0±109.0 144.9±79.2 0.112
Hemoglobin (×g/dL) (means±SD) 111.0±24.5 112.5±28.0 109.6±20.8 0.420
MO (means±SD) 7.0±3.1 6.9±3.1 7.1±3.1 0.577
Stay in hospital (days) (medians) 20.0 (12.0, 36.5) 18.0 (13.0, 29.0) 22.5 (12.0, 51.0) 0.038
APACHE II scores
(medians)
16.00 (12.0, 26.0) 16.0 (10.0, 23.5) 17.0 (13.0, 26.0) 0.099
ATN-ISI scores (medians) 0.335 (0.21, 0.58) 0.28 (0.15, 0.59) 0.34 (0.24, 0.58) 0.032
SAPS II scores (medians) 43.0 (31.0, 60.5) 42.5 (24.0, 57.25) 44.0 (35.0, 62.0) 0.048
SOFA scores (medians) 6.0 (3.0, 11.0) 6.0 (4.0, 12.0) 6.0 (3.0, 11.0) 0.703
RIFLE 0.272
Fc, n (%) 55 (30.4) 34 (29.1) 21 (32.8)
Ic, n (%) 47 (26.0) 27 (49.0) 20 (31.2)
Rc, n (%) 79 (43.6) 56 (47.9) 23 (35.9)

The various parameters were obtained within the first 24 hours following admission.

ALT, alanine amino transaminase; APACHE II, Acute Physiology and Chronic Health Evaluation version II; ATN-ISI, Acute Tubular Necrosis Individual Severity Index; BUN, serum urea nitrogen; Ca, serum calcium; Cho, serum total cholesterol Cl, serum chlorine;  Fc, F stage of the Risk, Injury, Failure, Loss, or End-stage kidney disease criteria; HDL, High density lipoprotein; Ic, I stage of the Risk, Injury, Failure, Loss, or End-stage kidney disease criteria; K, serum potassium; LDL, low density lipoprotein; MO, monocyte; Na, serum sodium; P, serum phosphorus; RBC, total blood count of red blood cell; RIFLE, Risk, Injury, Failure, Loss, or End-stage kidney disease; Rc, R stage of the Risk, Injury, Failure, Loss, or End-stage kidney disease criteria; SAPS II, Simplified Acute Physiology Score version II; SCr, serum creatinine; SOFA, Sepsis-related Organ Failure Assessment; WBC, total blood count of white cell count; TB, total protein; TG, triglyceride; Ua, uric acid;